Therapeutic effect of magnesium lithospermate B on neointimal formation after balloon-induced vascular injury

European Journal of Pharmacology

Volumn 586, Issue 1-3, 2008, Pages 226-233

  Hur, Kyu Yeon ^a,b   Seo, Hye Jun ^a   Kang, Eun Seok ^a,b   Kim, Soo Hyun ^b   Song, Seungjeong ^c   Kim, Eun Hee ^a   Lim, Soyeon ^a,b   Choi, Chulhee ^c   Heo, Ji Hoe ^a,b   Hwang, Ki Chul ^b   Ahn, Chul Woo ^a,b   Cha, Bong Soo ^a,b   Jung, Mankil ^a   Lee, Hyun Chul ^a,b  

^a Yonsei University   (South Korea)

^b Yonsei University College of Medicine   (South Korea)

^c Korea Advanced Institute of Science and Technology (KAIST)   (South Korea)

Author keywords

Magnesium lithospermate B; Neointimal formation; Platelet derived growth factor; Reactive oxygen species; Vascular smooth muscle cell

Indexed keywords

3 (4,5 DIMETHYL 2 THIAZOLYL) 2,5 DIPHENYLTETRAZOLIUM BROMIDE; MAGNESIUM LITHOSPERMATE; MITOGEN ACTIVATED PROTEIN KINASE; PHOSPHATIDYLINOSITOL 3 KINASE; PLATELET DERIVED GROWTH FACTOR AA; PLATELET DERIVED GROWTH FACTOR AB; PLATELET DERIVED GROWTH FACTOR BB; PROTEIN KINASE B; REACTIVE OXYGEN METABOLITE; SCAVENGER; XANTHINE; XANTHINE OXIDASE;

ANIMAL CELL; ANIMAL CELL CULTURE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIOXIDANT ACTIVITY; ARTERY INTIMA PROLIFERATION; ARTICLE; BALLOON; CAROTID ARTERY INJURY; CELL MIGRATION; CELL PROLIFERATION; CONTROLLED STUDY; DRUG EFFECT; DRUG MECHANISM; DRUG POTENCY; IN VITRO STUDY; IN VIVO STUDY; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; SIGNAL TRANSDUCTION; SMOOTH MUSCLE FIBER; VASCULAR SMOOTH MUSCLE;

ANGIOGENESIS INHIBITORS; ANIMALS; ANTIOXIDANTS; AORTA, THORACIC; BALLOON DILATATION; BLOTTING, WESTERN; CAROTID ARTERY INJURIES; CELL MOVEMENT; CELL PROLIFERATION; CELL SEPARATION; DRUGS, CHINESE HERBAL; ELECTROPHORESIS, POLYACRYLAMIDE GEL; FREE RADICAL SCAVENGERS; IMMUNOHISTOCHEMISTRY; MALE; MYOCYTES, SMOOTH MUSCLE; NEOVASCULARIZATION, PATHOLOGIC; PLANT ROOTS; PLATELET-DERIVED GROWTH FACTOR; RATS; RATS, SPRAGUE-DAWLEY; REACTIVE OXYGEN SPECIES; SALVIA MILTIORRHIZA; SIGNAL TRANSDUCTION;

EID: 43549099498     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejphar.2008.02.072     Document Type: Article

References (37)

1. Bae Y.S., Sung J.Y., Kim O.S., Kim Y.J., Hur K.C., Kazlauskas A., and Rhee S.G. Platelet-derived growth factor-induced H(2)O(2) production requires the activation of phosphatidylinositol 3-kinase. J. Biol. Chem. 275 (2000) 10527-10531
2. Cheng T.O. Cardiovascular effects of Danshen. Int. J. Cardiol 121 (2007) 9-22
3. Detre K., Holubkov R., Kelsey S., Cowley M., Kent K., Williams D., Myler R., Faxon D., Holmes Jr. D., Bourassa M., et al. Percutaneous transluminal coronary angioplasty in 1985-1986 and 1977-1981. The National Heart, Lung, and Blood Institute Registry. N. Engl. J. Med. 318 (1988) 265-270
4. Dzau V.J., Braun-Dullaeus R.C., and Sedding D.G. Vascular proliferation and atherosclerosis: new perspectives and therapeutic strategies. Nat. Med. 8 (2002) 1249-1256
5. Fung K.P., Zeng L.H., Wu J., Wong H.N., Lee C.M., Hon P.M., Chang H.M., and Wu T.W. Demonstration of the myocardial salvage effect of lithospermic acid B isolated from the aqueous extract of Salvia miltiorrhiza. Life Sci. 52 (1993) PL239-PL244
6. Gennaro G., Menard C., Michaud S.E., Deblois D., and Rivard A. Inhibition of vascular smooth muscle cell proliferation and neointimal formation in injured arteries by a novel, oral mitogen-activated protein kinase/extracellular signal-regulated kinase inhibitor. Circulation 110 (2004) 3367-3371
7. Ghigliotti G., Mereto E., Eisenberg P.R., Martelli A., Orsi P., Sini D., Spallarossa P., Olivotti L., and Brunelli C. N-acetyl-cysteine reduces neointimal thickening and procoagulant activity after balloon-induced injury in abdominal aortae of New Zealand white rabbits. Thromb. Haemost. 85 (2001) 724-729
8. Heldin C.H., and Westermark B. Mechanism of action and in vivo role of platelet-derived growth factor. Physiol. Rev. 79 (1999) 1283-1316
9. Higaki M., Sakaue H., Ogawa W., Kasuga M., and Shimokado K. Phosphatidylinositol 3-kinase-independent signal transduction pathway for platelet-derived growth factor-induced chemotaxis. J. Biol. Chem. 271 (1996) 29342-29346
10. Huang Y.S., and Zhang J.T. Antioxidative effect of three water-soluble components isolated from Salvia miltiorrhiza in vitro. Yao Xue Xue Bao 27 (1992) 96-100
11. Jagadeesha D.K., Lindley T.E., Deleon J., Sharma R.V., Miller F., and Bhalla R.C. Tempol therapy attenuates medial smooth muscle cell apoptosis and neointima formation after balloon catheter injury in carotid artery of diabetic rats. Adv. Physiol. Educ. 289 (2005) H1047-H1053
12. Jung M., Lee H.C., Ahn C.W., Park W., Choi S., Kim H., Cho D., Lee G.T., and Li H.R. Effective isolation of magnesium lithospermate B and its inhibition of aldose reductase and fibronectin on mesangial cell line. Chem. Pharm. Bull. 50 (2002) 1135-1136
13. Kappert K., Sparwel J., Sandin A., Seiler A., Siebolts U., Leppanen O., Rosenkranz S., and Ostman A. Antioxidants relieve phosphatase inhibition and reduce PDGF signaling in cultured VSMCs and in restenosis. Arterioscler. Thromb. Vasc. Biol. 26 (2006) 2644-2651
14. Lai K., Wang H., Lee W.S., Jain M.K., Lee M.E., and Haber E. Mitogen-activated protein kinase phosphatase-1 in rat arterial smooth muscle cell proliferation. J. Clin. Invest. 98 (1996) 1560-1567
15. Lee G.T., Ha H., Jung M., Li H., Hong S.W., Cha B.S., Lee H.C., and Cho Y.D. Delayed treatment with lithospermate B attenuates experimental diabetic renal injury. J. Am. Soc. Nephrol. 14 (2003) 709-720
16. Lee S., Lim H.J., Park H.Y., Lee K.S., Park J.H., and Jang Y. Berberine inhibits rat vascular smooth muscle cell proliferation and migration in vitro and improves neointima formation after balloon injury in vivo. Berberine improves neointima formation in a rat model. Atherosclerosis 186 (2006) 29-37
17. Leppanen O., Janjic N., Carlsson M.A., Pietras K., Levin M., Vargeese C., Green L.S., Bergqvist D., Ostman A., and Heldin C.H. Intimal hyperplasia recurs after removal of PDGF-AB and -BB inhibition in the rat carotid artery injury model. Arterioscler. Thromb. Vasc. Biol. 20 (2000) E89-E95
18. Liu C.S., Cheng Y., Hu J.F., Zhang W., Chen N.H., and Zhang J.T. Comparison of antioxidant activities between salvianolic acid B and Ginkgo biloba extract (EGb 761). Acta Pharmacol. Sin. 27 (2006) 1137-1145
19. Lyle A.N., and Griendling K.K. Modulation of vascular smooth muscle signaling by reactive oxygen species. Physiology 21 (2006) 269-280
20. Majesky M.W., Reidy M.A., Bowen-Pope D.F., Hart C.E., Wilcox J.N., and Schwartz S.M. PDGF ligand and receptor gene expression during repair of arterial injury. J. Cell Biol. 111 (1990) 2149-2158
21. Miyauchi K., Aikawa M., Tani T., Nakahara K., Kawai S., Nagai R., Okada R., and Yamaguchi H. Effect of probucol on smooth muscle cell proliferation and dedifferentiation after vascular injury in rabbits: possible role of PDGF. Cardiovasc. Drugs Ther. 12 (1998) 251-260
22. Nunes G.L., Robinson K., Kalynych A., King III S.B., Sgoutas D.S., and Berk B.C. Vitamins C and E inhibit O2-production in the pig coronary artery. Circulation 96 (1997) 3593-3601
23. Ohba M., Shibanuma M., Kuroki T., and Nose K. Production of hydrogen peroxide by transforming growth factor-beta 1 and its involvement in induction of egr-1 in mouse osteoblastic cells. J. Cell Biol. 126 (1994) 1079-1088
24. Rhee S.G., Kang S.W., Jeong W., Chang T.S., Yang K.S., and Woo H.A. Intracellular messenger function of hydrogen peroxide and its regulation by peroxiredoxins. Curr. Opin. Cell Biol. 17 (2005) 183-189
25. Schwartz S.M. Smooth muscle migration in atherosclerosis and restenosis. J. Clin. Invest 100 (1997) S87-S89
26. Schwartz R.S., Holmes Jr. D.R., and Topol E.J. The restenosis paradigm revisited: an alternative proposal for cellular mechanisms. J. Am. Coll. Caridol. 20 (1992) 1284-1293
27. Shigematsu T., Tajima S., Nishikawa T., Murad S., Pinnel S.R., and Nishioka I. Inhibition of collagen hydroxylation by lithospermic acid magnesium salt, a novel compound isolated from Salviae miltiorrhizae Radix. Biochimica et Biophysica Acta 1200 (1994) 79-83
28. Sorescu D., Somers M.J., Lassegue B., Grant S., Harrison D.G., and Griendling K.K. Electron spin resonance characterization of the NAD(P)H oxidase in vascular smooth muscle cells. Free Radic. Biol. Med. 30 (2001) 603-612
29. Souza H.P., Souza L.C., Anastacio V.M., Pereira A.C., Junqueira M.L., Krieger J.E., da Luz P.L., Augusto O., and Laurindo F.R. Vascular oxidant stress early after balloon injury: evidence for increased NAD(P)H oxidoreductase activity. Free Radic. Biol. Med. 28 (2000) 1232-1242
30. Sundaresan M., Yu Z.X., Ferrans V.J., Irani K., and Finkel T. Requirement for generation of H2O2 for platelet-derived growth factor signal transduction. Science 270 (1995) 296-299
31. Szocs K., Lassegue B., Sorescu D., Hilenski L.L., Valppu L., Couse T.L., Wilcox J.N., Quinn M.T., Lambeth J.D., and Griendling K.K. Upregulation of Nox-based NAD(P)H oxidases in restenosis after carotid injury. Arterioscler. Thromb. Vasc. Biol. 22 (2002) 21-27
32. Weber D.S., Taniyama Y., Rocic P., Seshiah P.N., Dechert M.A., Gerthoffer W.F., and Griendling K.K. Phosphoinositide-dependent kinase 1 and p21-activated protein kinase mediate reactive oxygen species-dependent regulation of platelet-derived growth factor-induced smooth muscle cell migration. Circ. Res. 94 (2004) 1219-1226
33. Wu X.J., Wang Y.P., Wang W., Sun W.K., Xu Y.M., and Xuan L.J. Free radical scavenging and inhibition of lipid peroxidation by magnesium lithospermate B. Acta Pharmacol. Sin. 21 (2000) 855-858
34. Yan Z., and Hansson G.K. Overexpression of inducible nitric oxide synthase by neointimal smooth muscle cells. Circulation research 82 (1998) 21-29
35. Yokozawa T., Lee T.W., Oura H., Nonaka G., and Nishioka I. Effect of magnesium lithospermate B in rats with sodium-induced hypertension and renal failure. Nephron 60 (1992) 460-465
36. Yokozawa T., Dong E., Oura H., Kashiwagi H., Nonaka G., and Nishioka I. Magnesium lithospermate B suppresses the increase of active oxygen in rats after subtotal nephrectomy. Nephron 75 (1997) 88-93
37. Zhou L., Zuo Z., and Chow M.S. Danshen: an overview of its chemistry, pharmacology, pharmacokinetics, and clinical use. J. Clin. Pharmocol. 45 (2005) 1345-1359